Ledger.Open graph →
SEC Form D · Amendment · filed December 13, 2012

Morria Biopharmaceuticals PLC

Offering
$1.5M
Sold
$1.5M
Exemption
—
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

People & firms on this filing (17)

Piney Point Capital GP LLC · Milwaukee, WIDirectorMark Cohen · NEW YORK, NYDirectorYuval Cohen · LONDON, United KingdomExec · DirectorGilead Raday · KEFAR-URIA, L3DirectorDov Elefant · LONDON, United KingdomExecSaul Yedgar · JERUSALEM, L3Exec · DirectorAmos Eiran · HERZELIYA, L3DirectorAlan Harris · NEW YORK, NYExecNicola (Nick) Sanna · Spokane, WADirectorUri Foox · New York, NYExec · DirectorEliot Buchanan · Boston, MAExecKerry Hatch · Boston, MAExec · DirectorDaniel Choi · Boston, MADirectorMichail Medvinsky · Boston, MADirectorDavid L. Potter · Tampa, FLDirectorRobert Dobbs · Tampa, FLExecDavid Sidransky · Somerset, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗